2014
DOI: 10.1016/j.bbi.2014.02.014
|View full text |Cite
|
Sign up to set email alerts
|

Matrix metalloproteinase-3 is a possible mediator of neurodevelopmental impairment due to polyI:C-induced innate immune activation of astrocytes

Abstract: Increasing epidemiological evidence indicates that prenatal infection and childhood central nervous system infection with various viral pathogens enhance the risk for several neuropsychiatric disorders. Polyriboinosinic-polyribocytidilic acid (polyI:C) is known to induce strong innate immune responses that mimic immune activation by viral infections. Our previous findings suggested that activation of the innate immune system in astrocytes results in impairments of neurite outgrowth and spine formation, which l… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 16 publications
(21 citation statements)
references
References 59 publications
0
21
0
Order By: Relevance
“…Oxidative stress may be a common pathological mechanism leading to the impairment of PV (+) GABAergic interneurons (Steullet et al, ). We should investigate in future whether neuropathological changes such as microglial activation in sH‐2D‐expressing mice are mainly related to MHCI or another molecule expressed and released by astrocytes (Liddelow et al, ; Steullet et al, ; Yamada et al, ). Further studies are needed to clarify that the behavioral and neuropathological changes in sH‐2D‐expressing mice are associated with astrocyte‐derived exosomes.…”
Section: Discussionmentioning
confidence: 99%
“…Oxidative stress may be a common pathological mechanism leading to the impairment of PV (+) GABAergic interneurons (Steullet et al, ). We should investigate in future whether neuropathological changes such as microglial activation in sH‐2D‐expressing mice are mainly related to MHCI or another molecule expressed and released by astrocytes (Liddelow et al, ; Steullet et al, ; Yamada et al, ). Further studies are needed to clarify that the behavioral and neuropathological changes in sH‐2D‐expressing mice are associated with astrocyte‐derived exosomes.…”
Section: Discussionmentioning
confidence: 99%
“…Astrocyte culture was performed as described previously (Ibi et al, 2013;Yamada et al, 2014). Briefly, astrocytes were isolated from the cortices and hippocampi of the postnatal (day 0-2) ICR mice.…”
Section: Astrocyte Culturementioning
confidence: 99%
“…Meanwhile, astrocytes also coordinate immune response to invading pathogens and peripheral inflammatory factors [ 60 ]. In fact, it has been reported that thousands of molecules are released from astrocytes responding to pro- and anti-inflammatory cytokines and TLR ligands such as bacterial LPS and specific nucleic acids like polyI:C [ 40 , 61 , 62 , 63 , 64 , 65 ]. Astrocytes exposed with maternally derived cytokines after MIA seem to secrete various cytokines that affect brain development.…”
Section: Astrocyte As a Possible Therapeutic Targetmentioning
confidence: 99%
“…Astrocytes exposed with maternally derived cytokines after MIA seem to secrete various cytokines that affect brain development. Regarding TLRs expressed in astrocytes, it is noteworthy that TLR 3 is the predominant one [ 40 , 63 , 64 ], given that the basal expression levels of TLR 3 in neurons and microglia are even lower than in astrocytes [ 40 , 63 ]. PolyI:C and viral nucleic acids supposedly target the TLR 3 of astrocytes in either the brain or the BBB.…”
Section: Astrocyte As a Possible Therapeutic Targetmentioning
confidence: 99%
See 1 more Smart Citation